Lisa Wilson
Investor Relations
Replay available
TherapeuticsMD, Inc. (TXMD) Q3 2021 Earnings Call
TherapeuticsMD, Inc. (NASDAQ: TXMD) Q3 2021 earnings conference call, held 2021-11-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Douglas South
Equity Research Analyst, H.C. Wainwright
James DiRocca
Chief Financial Officer
Rob Fenizio
Chief Executive Officer
Hugh O'Dowd
President and Chief Executive Officer
Mark Glickman
Chief Commercial Officer
Louise Chin
Analyst, Cantor Fitzgerald
Annabelle Samamy
Analyst, Stifel
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Therapeuticsmd, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:05.291 Good morning, ladies and gentlemen. Thank you for joining us for the Therapeutics MD 00:00:05.291 -- 00:00:09.472 Third Quarter 2021 Financial Results Conference Call. 00:00:09.472 -- 00:00:14.053 Following prepared remarks from the company, we will open the call for questions. 00:00:14.053 -- 00:00:18.775 I would now like to turn the call over to Lisa Wilson, Investor Relations for Therapeutics 00:00:18.775 -- 00:00:21.715 MD. Lisa? 00:00:28.618 -- 00:00:33.683 Thank you, Operator. Good morning, everyone, and thank you for joining today 00:00:33.683 -- 00:00:38.146 to discuss our third quarter financial results and business update. 00:00:38.146 -- 00:00:40.488 This morning, TherapeuticsMD 00:00:40.488 -- 00:00:44.331 issued a press release announcing our third quarter financial results. 00:00:44.331 -- 00:00:49.955 The press release and accompanying presentation are available on the company's website, 00:00:49.955 -- 00:00:51.756 therapeuticsmd.com, 00:00:51.756 -- 00:00:54.618 in the Investors and Media section. 00:00:54.618 -- 00:00:57.180 On today's call from TherapeuticsMD, 00:00:57.180 -- 00:01:01.283 our Chief Executive Officer, Rob Fenizio, 00:01:01.283 -- 00:01:03.764 President Hugh O'Dowd, 00:01:03.764 -- 00:01:06.784 Chief Financial Officer James Durecka, 00:01:06.784 -- 00:01:09.965 and Chief Commercial Officer Mark Glickman. 00:01:09.965 -- 00:01:13.686 I would like to remind everyone that certain statements made during this conference call 00:01:13.686 -- 00:01:18.827 may be forward-looking statements. Such forward-looking statements are based upon current 00:01:18.827 -- 00:01:23.648 expectations, and there can be no assurance that the results contemplated in these statements 00:01:23.648 -- 00:01:25.669 will be real...